| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |